In the intricate world of pharmaceutical manufacturing, the quality and reliability of chemical intermediates are paramount. N,N-Dimethylaminobutane, identified by CAS 927-62-8, plays a vital role as a tertiary amine intermediate, enabling the synthesis of complex molecules essential for drug development. Understanding its manufacturing significance and chemical properties can illuminate its value for B2B stakeholders.

N,N-Dimethylaminobutane, with its chemical formula C6H15N, is a colorless liquid characterized by a molecular weight of 101.19. Its utility is rooted in its chemical structure, specifically the presence of a dimethylamino group attached to a butyl chain. This configuration makes it a versatile reagent in organic synthesis. The high purity standards, typically 99.0% or more, are critical for its application as a pharmaceutical intermediate, ensuring that the subsequent reactions yield the desired product with minimal impurities.

The manufacturing of pharmaceutical intermediates like N,N-Dimethylaminobutane involves precise chemical processes to achieve the required purity and specifications. As a supplier, ensuring a consistent production output and stringent quality control measures are key. The physical properties, such as its low melting point (-60 °C) and boiling point (93.3 °C), are favorable for industrial handling and processing, contributing to its widespread use.

The application of N,N-Dimethylaminobutane as a pharmaceutical intermediate is its most prominent use. It serves as a foundational chemical building block, allowing for the construction of more complex molecules that form the basis of many medications. Its specific reactivity profile makes it suitable for various synthetic transformations, leading to the development of novel therapeutic agents. For companies looking to buy this compound, understanding its specific role in synthesis is crucial for optimizing their procurement strategy.

For businesses seeking to acquire N,N-Dimethylaminobutane, partnering with reputable manufacturers and suppliers, especially those in China, can offer distinct advantages. These suppliers often provide access to high-quality products at competitive prices. When evaluating potential suppliers, it’s important to request detailed specifications, safety data, and Certificates of Analysis. The ability to secure a steady supply at a reasonable price is a critical factor for pharmaceutical companies managing their production costs.

The demand for reliable sources of N,N-Dimethylaminobutane is driven by the global pharmaceutical industry's constant need for innovation and production. Therefore, establishing strong relationships with suppliers who can consistently deliver this key intermediate is essential. Whether you are a researcher exploring new synthetic routes or a production manager overseeing large-scale manufacturing, having a dependable source for this chemical is a significant advantage.

In essence, N,N-Dimethylaminobutane (CAS 927-62-8) is more than just a chemical compound; it is a critical enabler in pharmaceutical manufacturing. Its purity, reactivity, and availability, underpinned by robust manufacturing and supply chain practices, make it an indispensable component for advancing drug development and production.